What is MiMedx Group's D&A?

MiMedx Group (MDXG) reported D&A of $301K in Q1 2026.

How has MiMedx Group's D&A changed year-over-year?

MiMedx Group's D&A increased by 204.0% year-over-year, from $99K to $301K.

What is the long-term trend for MiMedx Group's D&A?

Over 4 years (2021 to 2025), MiMedx Group's D&A has grown at a -14.4% compound annual growth rate (CAGR), from $820K to $440K.

Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.

MiMedx Group MDXG D&A

D&A at other companies

ArtivionAORT

$6.34M+16.4%

EnovisENOV

$41.9M+0.2%

CorMedixCRMD

$10.54M+20,197%

Globus MedicalGMED

$29.53M-55.3%

Medline, Inc. MDLN

$254M+2.8%

SolventumSOLV

——

Other financials

Income statement

See full

Revenue$59.0M-33.1%

Gross profit$41.6M-41.9%

Operating income-$16.0M-295%

Net income-$10.9M-255%

EPS (diluted)-$0.07-240%

Balance sheet

See full

Cash & equivalents$159.8M+50.1%

Total debt$17.6M-5.7%

Total equity$242.9M+19.8%

Total assets$308.7M+14.1%

Cash flow

See full

Operating cash flow$1.9M-64.5%

CapEx$570.0K+51.2%

Free cash flow$1.3M-73.4%

Valuation

See full

Market cap$567.48M-33.9%

Enterprise value$425.3M-44.8%

P/E18.5×-2.9×

P/S1.5×-1.0×

Profitability

See full

Gross margin81%-0.9pp

Operating margin10.2%-5.1pp

Net margin7.9%-3.5pp

FCF margin17.8%-0.5pp

Returns & leverage

See full

Return on equity13.8%-8.6pp

Debt / equity0.1×0.0×

Current ratio5.4×+0.7×

Where this comes from

Reported directly by MiMedx Group in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.

The official record: MiMedx Group’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about MiMedx Group's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MiMedx Group's D&A?: MiMedx Group (MDXG) reported D&A of $301K in Q1 2026.
How has MiMedx Group's D&A changed year-over-year?: MiMedx Group's D&A increased by 204.0% year-over-year, from $99K to $301K.
What is the long-term trend for MiMedx Group's D&A?: Over 4 years (2021 to 2025), MiMedx Group's D&A has grown at a -14.4% compound annual growth rate (CAGR), from $820K to $440K.
What does D&A mean?: Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.